Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03190070 · ClinicalTrials.gov registry record · NA
Measurement of Renal Functional Reserve
A NA study of Kidney Diseases, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT03190070: Completed NA study of Kidney Diseases, sponsored by Brigham and Women's Hospital.
NCT03190070 is a NA study of Kidney Diseases that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 47 participants, below the 1,784-participant average among 38 other Kidney Diseases trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03190070, a NA study of Kidney Diseases, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
Single arm physiological study to measure renal functional reserve as a biomarker of kidney function and health
Primary Outcome
Short term-changes in the glomerular filtration rate will be measured before and after ingestion of oral protein
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Ingestion of protein
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2017-07-12 |
| Est. Completion | 2021-12-01 |
| Phase | NA |
What the finished NCT03190070 record still lists
NCT03190070 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,784-participant average among 38 other Kidney Diseases trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which Ingestion of protein is the first listed.
NCT03190070 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03190070 about?
NCT03190070 is a clinical study titled "Measurement of Renal Functional Reserve". Single arm physiological study to measure renal functional reserve as a biomarker of kidney function and health
What is the current status of trial NCT03190070?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2017-07-12. Estimated completion is 2021-12-01.
What conditions does trial NCT03190070 study?
This clinical trial studies the following conditions: Kidney Diseases.
What interventions are being tested in trial NCT03190070?
The interventions under investigation include: Ingestion of protein (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03190070?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03190070 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03190070's enrollment target sits among peer trials
47 30th of 38 higher than 9 of 38 other Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
RECRUITING · NA
-
Supporting VETerans With Kidney Disease Through Food As Medicine
RECRUITING · NA
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
-
Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI